Fundamentals of Toxicology - Vocabulary Flashcards

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/57

flashcard set

Earn XP

Description and Tags

A set of vocabulary-style flashcards covering key terms and concepts from Lecture 2: Fundamentals of toxicology, including spectrum of effects, exposure, dose–response, interactions, risk metrics, and systems toxicology.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

58 Terms

1
New cards

Adverse effects (toxic effects)

Effects of a drug that are never desirable and are harmful (adverse or toxic effects).

2
New cards

Allergic reaction

Adverse immune response to a chemical requiring prior exposure (sensitization).

3
New cards

Sensitization

Prior exposure to a chemical that enables a subsequent toxic or allergic response.

4
New cards

Idiosyncratic reaction

Abnormal reactivity to a chemical based on genetics or other individual sensitivity factors.

5
New cards

Agranulocytosis

Life-threatening reduction in neutrophils due to bone marrow suppression.

6
New cards

Aplastic anemia

Bone marrow failure leading to insufficient production of neutrophils and erythrocytes.

7
New cards

Immediate toxicity

Toxic effects that are observable soon after exposure.

8
New cards

Delayed toxicity

Toxic effects that take months or years to become evident after exposure.

9
New cards

Reversible toxicity

Toxic effects that tissue can adapt to, repair, or recover from.

10
New cards

Irreversible toxicity

Toxic effects that cause permanent damage (e.g., cancers, birth defects).

11
New cards

Local toxicity

Toxic effects that occur at the site of first contact with the toxicant.

12
New cards

Systemic toxicity

Toxic effects that occur after absorption and distribution to distant sites.

13
New cards

Antagonism

Interaction where combined effects are less than the sum of individual effects.

14
New cards

Receptor antagonism

Two chemicals compete for the same receptor, reducing each other's effect.

15
New cards

Chemical antagonism

Direct chemical reaction between two compounds producing a less toxic product.

16
New cards

Dispositional antagonism

Alteration of absorption, distribution, metabolism, or excretion reducing target site exposure.

17
New cards

Functional antagonism

Two chemicals counterbalance each other by affecting the same physiological function.

18
New cards

Additivity

Combined effect equals the sum of individual effects.

19
New cards

Toxicity Equivalence Factor (TEF)

A relative potency factor that compares dioxin-like compounds to a reference (TCDD).

20
New cards

Dioxins

Family of structurally related persistent environmental pollutants (e.g., TCDD) with toxic properties.

21
New cards

Total Toxic Equivalents (TEQ)

Sum of (concentration × TEF) for dioxin-like compounds in a mixture.

22
New cards

Aryl hydrocarbon receptor (AhR)

Ligand-activated transcription factor activated by dioxins/PAHs/PCBs that regulates gene expression linked to toxicity and cancer.

23
New cards

AhR-ARNT complex

Dimer of AhR with ARNT that binds to AHREs to initiate transcription of target genes.

24
New cards

Xenobiotic-metabolizing enzymes

Enzymes (e.g., CYP1A1, CYP1A2, CYP1B1) induced by AhR signaling to metabolize xenobiotics.

25
New cards

Detoxification pathway (NQO1)

Phase II/detox genes that help neutralize oxidative stress, potentially involved in cancer risk when overactivated.

26
New cards

Immunosuppression via AhR

Chronic AhR activation can promote regulatory T cells and dampen anti-tumor immunity.

27
New cards

Dose–response relationship

Association between the amount of toxic exposure and the extent of biological change.

28
New cards

ED50

Dose that induces a response in 50% of a population.

29
New cards

LD50/LC50

Lethal dose/ lethal concentration for 50% of a population.

30
New cards

TD1

Toxic dose that produces a specified effect in 1% of a population (example metric).

31
New cards

NOAEL

No Observed Adverse Effect Level—the highest dose with no significant adverse effects observed.

32
New cards

LOAEL

Lowest Observed Adverse Effect Level—the lowest dose at which adverse effects are observed.

33
New cards

MOE (Margin of Exposure)

Exposed dose divided by NOAEL; used for chemicals without beneficial effects.

34
New cards

Margin of Safety (MOS)

TD1 to ED99 or similar comparison; alternative metric to gauge safety margins.

35
New cards

Therapeutic Index (TI)

Ratio of toxic dose to therapeutic dose; wider TI indicates safer drug.

36
New cards

Margin of Safety (MOS) (environmental contaminants)

MOE-type concept applied when no beneficial effect exists; compares exposure to NOAEL/LOAEL.

37
New cards

Potency

Amount of substance needed to produce a given effect; lower dose for same effect means higher potency.

38
New cards

Efficacy

Maximum effect a substance can produce, regardless of dose.

39
New cards

Synergism

Combined effect of two chemicals is greater than the sum of their separate effects.

40
New cards

Potentiation

One chemical increases the toxicity of another without sharing the same toxic effect.

41
New cards

Dose extrapolation across species

Using body surface area (not body weight) to convert doses when translating from animals to humans.

42
New cards

MRSD (Maximum Recommended Starting Dose)

Highest dose tested in animals that does not cause significant toxicity, used to start human trials.

43
New cards

Therapeutic index vs margin of safety

TI compares TD50 to ED50; MOS/ MOE compare exposure to NOAEL or ED99 to assess safety.

44
New cards

Quantal vs graded dose–response

Quantal: population-level all-or-none responses; Graded: continuous response in individuals.

45
New cards

Monotonic dose–response curve

Response increases (or decreases) steadily with dose.

46
New cards

Nonmonotonic dose–response curve (hormesis)

Curve with multiple inflection points; low-dose stimulation with high-dose toxicity.

47
New cards

Threshold model

Toxicity appears only above a certain dose; no effects below threshold.

48
New cards

Linear, nonthreshold model

Proportional dose–response without a safe threshold; used for genotoxic carcinogens and ionizing radiation.

49
New cards

AOP (Adverse Outcome Pathway)

Framework linking molecular initiating events to adverse outcomes through a chain of key events.

50
New cards

Systems toxicology

Integrates toxicology with systems biology (genomics, proteomics, metabolomics) to study toxicity pathways.

51
New cards

Transcriptome

All mature mRNA species present in a cell at a given time.

52
New cards

Epigenome

Heritable changes in gene expression without altering DNA sequence (e.g., methylation, histone modification).

53
New cards

Proteome

Complete set of proteins expressed in a cell, tissue, or organism.

54
New cards

Metabonomics/Metabolomics

Analysis of small-molecule metabolites to assess biochemical pathways and responses.

55
New cards

DDT eggshell thinning hypothesis

DDT/DDE disrupt calcium metabolism causing thinner eggshells and reproductive failures in birds.

56
New cards

Selective toxicity

Ability of a chemical to affect a target organism or tissue while sparing others.

57
New cards

Species differences in toxicity

Different species can show different toxicokinetic and toxicodynamic responses to the same chemical.

58
New cards

Biomagnification

Increase in concentration of a toxin as it moves up the food chain.